China Usa city Shanghai province Jiangsu covid-19 testing vaccine Volunteers China Usa city Shanghai province Jiangsu

BioNTech, Fosun start Phase II trial of covid-19 vaccine in China

Reading now: 965
www.livemint.com

FRANKFURT : BioNTech and Shanghai Fosun Pharmaceutical said on Wednesday they would launch a Phase II clinical trial of BioNTech's experimental COVID-19 vaccine in China.The vaccine, known as BNT162b2, will be tested on volunteers at the Jiangsu Provincial Center for Disease Control and Prevention to assess safety and immunogenicity, eyeing future approval in China, the two companies said in a statement.BioNTech is also working with US pharma giant Pfizer on the vaccine and the partners said last week they were hoping to win approval in the United States and Europe this year after trial results showed the compound had a 95% efficacy rate and caused no serious side effects.Click here to read the Mint ePaperMint is now on Telegram.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA